智飞生物：2025年半年度净利润亏损约5.97亿元

Core Insights - The company reported a significant decline in revenue for the first half of 2025, with an approximate revenue of 4.919 billion yuan, representing a year-on-year decrease of 73.06% [2] - The net profit attributable to shareholders of the listed company showed a loss of approximately 597 million yuan [2] - The basic earnings per share reflected a loss of 0.2494 yuan [2]